Beaumont Asset Management, L.L.C. Moderna, Inc. Transaction History

Beaumont Asset Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$117.13 - $176.59 $351,624 - $530,123	-3,002 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$126.46 - $235.05 $8,725 - $16,218	69 Added 2.35%	3,002 $517,000
Q4 2021 Jan 25, 2022	BUY	$225.82 - $368.51 $27,098 - $44,221	120 Added 4.27%	2,933 $744,000
Q3 2021 Oct 20, 2021	BUY	$221.9 - $484.47 $6,878 - $15,018	31 Added 1.11%	2,813 $1.08 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $128,091 - $231,690	986 Added 54.9%	2,782 $653,000
Q1 2021 Apr 29, 2021	BUY	$109.18 - $185.98 $196,087 - $334,020	1,796 New	1,796 $235,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Beaumont Asset Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Beaumont Asset Management, L.L.C. with notifications on news.